Mesoporous multimetallic PdPtBi nanozymes target redox imbalance and glutamine deprivation for immuno-chemodynamic therapy
Open Access
- 24 November 2025
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1)
Abstract
Therapeutic resistance remains a formidable challenge in oncology, mainly due to the chaotic tumor microenvironment (TME), which drive tumor progression and adaptive resistance via a self-sustaining metabolic–oxidative feedback loop. Herein, a multifunctional nanotherapeutic platform based on PdPtBi multimetallic nanozymes (PPB MMNs) is rationally engineered to address these challenges by simultaneously targeting reactive oxygen species (ROS) modulation and glutamine (Gln) metabolic disruption. Specifically, the PPB MMNs display cascade enzyme-mimicking activities resembling peroxidase (POD), catalase (CAT), and glutathione oxidase (GOD-SH). These activities effectively promote the generation of reactive oxygen species (ROS) and facilitate the decomposition of endogenous H₂O₂ into O₂, thereby alleviating hypoxia and inducing oxidative stress. Upon ultrasound (US) activation, their catalytic performance is further amplified, enabling deep-tissue therapeutic efficacy. Concurrently, PPB MMNs impair Gln metabolism, aggravating redox dyshomeostasis and undermining tumor metabolic flexibility. Both in vitro and in vivo studies validate the superior antitumor activity of PPB MMNs in suppressing primary and metastatic tumor growth by disrupting the redox-metabolic axis. Collectively, our study offers a robust framework for designing multimodal nanomedicines that reprogram the TME and overcome resistance, opening new avenues for precise, synergistic cancer therapy based on redox and metabolic vulnerabilities.Keywords
Funding Information
- China Postdoctoral Science Foundation (2024M750452)
- China Postdoctoral Science Foundation (2024MD763947)
- National Natural Science Foundation of China (82402408)
- Guangxi Natural Science Foundation Key Project (2022GXNSFDA035060)
This publication has 46 references indexed in Scilit:
- Dual Strategy of Ca2+ Influx and Collagen Denaturation to Remodel the Extracellular Matrix and Amplify Sonopiezoelectric TherapyAdvanced Materials, 2025
- A Needle‐Like H2S‐Releasing and H2O2 Self‐Replenishing Nanoplatform for Enhanced Chemodynamic Tumor ImmunotherapyAdvanced Science, 2025
- Spatially Targeted PD‐L1 Blockade for Restoring Exhausted Cytotoxic T Lymphocyte Rejuvenation to Potentiate Multimodal‐Immune Synergistic Therapies for Breast Cancer TreatmentSmall, 2025
- Immunostimulatory Hydrogel with Synergistic Blockage of Glutamine Metabolism and Chemodynamic Therapy for Postoperative Management of GlioblastomaAdvanced Science, 2025
- The regulatory roles and clinical significance of glycolysis in tumorCancer Communications, 2024
- Nanozyme’s catalytic activity at neutral pH: reaction substrates and application in sensingAnalytical and Bioanalytical Chemistry, 2023
- Glutamine Metabolism in Cancer2021
- Overview of Glutamine Dependency and Metabolic Rescue Protocols2019
- The challenge of drug resistance in cancer treatment: a current overviewClinical & Experimental Metastasis, 2018
- Targeting the Metabolic Microenvironment of Tumors2012